Acute neuritis due to anti-myelin oligodendrocyte glycoprotein associated disease (MOGAD) improves without acute treatments, while myelitis due to MOGAD improves less if not treated, according to a ...

In patients with SCD, although the lifespan of their reticulocytes remains unknown, the number of immature reticulocytes is on the rise. Research has shown that reticulocytosis can predict morbidity ...

No temporarily associated relapses were observed in 25 patients vaccinated or boostered against meningococcal disease during ECU therapy. Eculizumab treatment reduces annualized attack rate (AAR) and ...

For SLE-related GBS and CIDP, treatment for primary disease should also be initiated in addition to first-line therapy for GBS and CIDP. Systemic lupus erythematosus (SLE) may manifest as chronic ...

The safety profile of WVE-006 has been favorable, with all reported adverse events being mild to moderate. No serious adverse events have been observed. WVE-006, an RNA editing therapy aimed at ...

In terms of the safety profile, 40 patients (37%) experienced injection site reactions as the most frequent adverse event. Real-world data confirms the safety profile of IgPro20 for patients with ...

Clonal dynamics varied across patients with advanced SM, with some subclones persisting despite treatment. Subclonal architecture analysis showed varying clonal dynamics, with some subclones ...

The researchers said that blood samples are ready for analysis and that preliminary results will be presented soon. The plan of a case-control study that will investigate the potential role of the ...

Which of the following statements about the pathophysiology of systemic mastocytosis (SM) are correct? Select one of the options for each question, then submit your answers to see how well you scored ...

Of the two entities, only NMOSD involved the brain, with 35.7% of the patients presenting with brain lesions. Spinal cord and brain imaging could narrow differential diagnosis for patients with ...

Recently, I became aware of a very real threat to my health as someone with alpha-1 antitrypsin deficiency (AATD). I have long dealt with acid reflux, even as early as my twenties. Recently, I woke up ...

In the Japanese open-label extension study, patients with CAD reported fewer treatment-emergent adverse events. One patient experienced mild urinary tract infection linked to sutimlimab. Sutimlimab ...